Common Household Cleaning Products May Cause Birth Defects

Common Household Cleaning Products May Cause Birth Defects

A recent study published in the journal Birth Defects Research has discovered that common cleaning products used in homes, hotels, and hospitals may lead to birth defects. The study was conducted on mice, and revealed that the animals didn’t even need to have direct contact with the chemicals. Just being in the same room as the disinfectants led to increased birth defect rates. [Read more…]

Monsanto’s Market-Dominating Weed Killers With Glyphosate Linked To Pregnancy Problems

New Study Finds Monsanto Weedkiller Chemical Increases Cancer Risk

A new study from the Children’s Environmental Health Network (“CEHN”) Healthy Kids Initiative testing 69 pregnant women, reveals  that exposure to the widely-used herbicide known as glyphosate accumulates in pregnant women and leads to unfavorable birth outcomes.

[Read more…]

Pro Publica: Why Drug Testing’s Omission of Pregnant Women May Have Led to Zofran Birth Defect Injuries

California Parents File Zofran Lawsuit Against GlaxoSmithKline

Pro Publica has published a lengthy article exploring how the medical establishment’s long-standing approach to “protecting” fetuses by restricting testing on pregnant women has resulted in a critical shortfall of knowledge. While the intention was mostly good — to protect women and babies from the kind of severe birth defects and other harm caused by thalidomide and other drugs in the 1960s and ‘70s (but also to protect pharmaceutical companies from legal liability for those injuries) — the result is less certain. By excluding women — and pregnant women in particular — from clinical trials, doctors have been forced into prescribing untried medications “off-label” to pregnant women, with results that can lead to serious negative health consequences for mothers, and birth defects for babies. [Read more…]

Zofran Birth Defect Lawsuits Consolidated in Massachusetts Federal Court

Zofran Birth Defect Lawsuits Consolidated in Massachusetts Federal Court

As reported by Law360, the US Judicial Panel on Multidistrict Litigation has consolidated in Massachusetts a number of lawsuits alleging that off-label promotion by GlaxoSmithKline of its anti-nausea drug Zofran for morning sickness led to serious birth defects. “The MDL panel found that 12 lawsuits, some of which are proposed class actions, warranted consolidation as they all involved common allegations that GlaxoSmithKline’s Zofran and its generic equivalent, Ondansetron … cause birth birth defects in children when their mothers ingest the drug while pregnant.” [Read more…]